ConductScience.org, home

Paper30596398

Inhibition of XPO1 enhances cell death induced by ABT-199 in acute myeloid leukaemia via Mcl-1.

Luedtke DA and 7 others. J Cell Mol Med, 2018. Cited by 54 papers, by iCite.

Cite this record

ConductScience Library. Inhibition of XPO1 enhances cell death induced by ABT-199 in acute myeloid leukaemia via Mcl-1. Papers, record 30596398. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30596398

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition of XPO1 enhances cell death induced by ABT-199 in acute myeloid leukaemia via Mcl-1.
PubMed
Journal
J Cell Mol Med
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
1.78
iCite
Revised in PubMed
2026-01-27
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Luedtke DADaniel A
2Su YYongwei
3Liu SShuang
4Edwards HHolly
5Wang YYue
6Lin HHai
7Taub JWJeffrey W
8Ge YYubinhttps://orcid.org/0000-0002-8748-716X

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
KaryopherinsMajor topic
Leukemia, Myeloid, AcuteMajor topic
Myeloid Cell Leukemia Sequence 1 ProteinMajor topic
Proto-Oncogene Proteins c-bcl-2Major topic
Receptors, Cytoplasmic and NuclearMajor topic
Adult
Aged
Apoptosis
Bridged Bicyclo Compounds, Heterocyclic
Cell Line, Tumor
Cell Proliferation
Drug Resistance, Neoplasm
Drug Synergism
Female
Gene Expression Regulation, Neoplastic
Humans
Hydrazines
Male
Middle Aged
Sulfonamides
Triazoles
Exportin 1 Protein

Source PubMed

Download CSV of topics

References53

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115361652Detection of mycoplasma contaminations.Methods Mol Biol2005https://conductscience.org/library/papers/15361652PubMed
224451410BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies.Leukemia2014https://conductscience.org/library/papers/24451410PubMed
327166183Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells.Oncotarget2016https://conductscience.org/library/papers/27166183PubMed
427520294Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia.Cancer Discov2016https://conductscience.org/library/papers/27520294PubMed
59150352The human bladder carcinoma cell line 5637 constitutively secretes functional cytokines.Leuk Res1997https://conductscience.org/library/papers/9150352PubMed
618097445The BCL-2 protein family: opposing activities that mediate cell death.Nat Rev Mol Cell Biol2008https://conductscience.org/library/papers/18097445PubMed
712783855Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation.Genes Dev2003https://conductscience.org/library/papers/12783855PubMed
89384386CRM1 is responsible for intracellular transport mediated by the nuclear export signal.Nature1997https://conductscience.org/library/papers/9384386PubMed
911260076In vivo suppression of Bcl-XL expression facilitates chemotherapy-induced leukaemia cell death in a SCID/NOD-Hu model.Br J Haematol2001https://conductscience.org/library/papers/11260076PubMed
1015687366GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.J Natl Cancer Inst2005https://conductscience.org/library/papers/15687366PubMed
117845007Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-C.Leukemia1995https://conductscience.org/library/papers/7845007PubMed
1219082467The expression of CRM1 is associated with prognosis in human osteosarcoma.Oncol Rep2009https://conductscience.org/library/papers/19082467PubMed
1327103402Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells.Clin Cancer Res2016https://conductscience.org/library/papers/27103402PubMed
1424346116Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia.Cancer Discov2014https://conductscience.org/library/papers/24346116PubMed
1518495871An essential role for MCL-1 in ATR-mediated CHK1 phosphorylation.Mol Biol Cell2008https://conductscience.org/library/papers/18495871PubMed
1620540941Mcl-1; the molecular regulation of protein function.FEBS Lett2010https://conductscience.org/library/papers/20540941PubMed
1719088047A phase I study of the pan bcl-2 family inhibitor obatoclax mesylate in patients with advanced hematologic malignancies.Clin Cancer Res2008https://conductscience.org/library/papers/19088047PubMed
1828336527A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia.Blood2017https://conductscience.org/library/papers/28336527PubMed
1923970380Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias.Blood2013https://conductscience.org/library/papers/23970380PubMed
2026202935Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG mice.Leukemia2016https://conductscience.org/library/papers/26202935PubMed

See all 53 referencesDownload CSV of references

Cited by44

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
42495755XPO1: From basic research to clinical treatment (Review).Oncol Rep2026https://conductscience.org/library/papers/42495755PubMed
41899095Resistance to Targeted Therapy in AML: Current Challenges and Emerging Treatment Strategies.J Clin Med2026https://conductscience.org/library/papers/41899095PubMed
41608989Targeting MCL-1 and MAPK overcomes venetoclax resistance in FLT3-ITD-positive AML cells harbouring activating PTPN11 (SHP-2) mutations.Br J Haematol2026https://conductscience.org/library/papers/41608989PubMed
40955793Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine.Mol Oncol2026https://conductscience.org/library/papers/40955793PubMed
40804253Comprehensive view on chemotherapy-free management of acute myeloid leukemia by using venetoclax in combination with targeted and/or immune therapies.Cell Death Discov2025https://conductscience.org/library/papers/40804253PubMed
40463909Selinexor in acute myeloid leukemia: therapeutic applications and current challenges.Front Pharmacol2025https://conductscience.org/library/papers/40463909PubMed
40100393Promising activity of Selinexor in the treatment of a patient with refractory NUP98-NSD1+/FLT3-ITD + acute myeloid leukemia.Ann Hematol2025https://conductscience.org/library/papers/40100393PubMed
40001478XPO1/Exportin-1 in Acute Myelogenous Leukemia; Biology and Therapeutic Targeting.Biomolecules2025https://conductscience.org/library/papers/40001478PubMed
39780285ONC213: a novel strategy to resensitize resistant AML cells to venetoclax through induction of mitochondrial stress.J Exp Clin Cancer Res2025https://conductscience.org/library/papers/39780285PubMed
39749030Selinexor in combination with venetoclax and decitabine in patients with refractory myelodysplastic syndrome previously exposed to hypomethylating agents: three case reports.Front Oncol2024https://conductscience.org/library/papers/39749030PubMed
39352544A review and perspective paper: Ras oncogene gets modest, from kingpin to mere henchman.Cell Mol Life Sci2024https://conductscience.org/library/papers/39352544PubMed
39307725[The clinical safety and efficacy of selinexor combined with venetoclax and azactitidine induction therapy in relapsed and refractory acute myeloid leukemia].Zhonghua Xue Ye Xue Za Zhi2024https://conductscience.org/library/papers/39307725PubMed
38987275The RNA helicases DDX19A/B modulate selinexor sensitivity by regulating MCL1 mRNA nuclear export in leukemia cells.Leukemia2024https://conductscience.org/library/papers/38987275PubMed
38266099The Imipridone ONC213 Targets α-Ketoglutarate Dehydrogenase to Induce Mitochondrial Stress and Suppress Oxidative Phosphorylation in Acute Myeloid Leukemia.Cancer Res2024https://conductscience.org/library/papers/38266099PubMed
38185524[Efficacy analysis of selinexor combined with hypomethylating agent in the treatment of refractory/relapsed acute myeloid leukemia exposed to venetoclax].Zhonghua Xue Ye Xue Za Zhi2023https://conductscience.org/library/papers/38185524PubMed
38049328[The development of selective XPO1 inhibitors in the treatment of acute myeloid leukemia].Zhonghua Xue Ye Xue Za Zhi2023https://conductscience.org/library/papers/38049328PubMed
38026089Selinexor Synergistically Promotes the Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia by Inhibiting Glycolytic Function and Downregulating the Expression of DNA Replication Genes.Immunotargets Ther2023https://conductscience.org/library/papers/38026089PubMed
37880950The Therapeutic Synergy of Selinexor and Venetoclax in Mantle Cell Lymphoma Through Induction of DNA Damage and Perturbation of the DNA Damage Response.Technol Cancer Res Treat2023https://conductscience.org/library/papers/37880950PubMed
37601075Real-world experience with selinexor-containing chemotherapy-free or low-dose chemotherapy regimens for patients with relapsed/refractory acute myeloid leukemia and myeloid sarcoma.Front Pharmacol2023https://conductscience.org/library/papers/37601075PubMed
37195589Update on Small Molecule Targeted Therapies for Acute Myeloid Leukemia.Curr Treat Options Oncol2023https://conductscience.org/library/papers/37195589PubMed

See all 44 cited byDownload CSV of cited by

Genes32

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ANXA5308PubTator's text mininghttps://conductscience.org/library/genes/308NCBI Gene
BAK1578PubTator's text mininghttps://conductscience.org/library/genes/578NCBI Gene
BAX581PubTator's text mininghttps://conductscience.org/library/genes/581NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BCL2L1598PubTator's text mininghttps://conductscience.org/library/genes/598NCBI Gene
BCL2L1110018PubTator's text mininghttps://conductscience.org/library/genes/10018NCBI Gene
BTRC8945PubTator's text mininghttps://conductscience.org/library/genes/8945NCBI Gene
CASP3836PubTator's text mininghttps://conductscience.org/library/genes/836NCBI Gene
CEBPA1050PubTator's text mininghttps://conductscience.org/library/genes/1050NCBI Gene
COL11A21302PubTator's text mininghttps://conductscience.org/library/genes/1302NCBI Gene
CSF21437PubTator's text mininghttps://conductscience.org/library/genes/1437NCBI Gene
CSF31440PubTator's text mininghttps://conductscience.org/library/genes/1440NCBI Gene
DNMT3A1788PubTator's text mininghttps://conductscience.org/library/genes/1788NCBI Gene
FANCB2187PubTator's text mininghttps://conductscience.org/library/genes/2187NCBI Gene
FBXW755294PubTator's text mininghttps://conductscience.org/library/genes/55294NCBI Gene
FLT32322PubTator's text mininghttps://conductscience.org/library/genes/2322NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
GATA22624PubTator's text mininghttps://conductscience.org/library/genes/2624NCBI Gene
GSK3B2932PubTator's text mininghttps://conductscience.org/library/genes/2932NCBI Gene
IL1B3553PubTator's text mininghttps://conductscience.org/library/genes/3553NCBI Gene

See all 32 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30596398

GET https://conductscience.org/api/papers/v1/30596398/references?page=2